DAY 2
Wednesday, 23 September 2026
08h00
Welcome Coffee
08h40
Strengthening QA/QC Systems to Support Compliance, Robustness and Performance
- E-Lounge Auditorium
Chairman
10h00
How to avoid a Complete Response Letters: Implications for Product Access
Natalia PRIPUZOVA
CEO, Founder & Regulatory Affairs CMC Consulting
NPDK Bioconsulting, USA
10h00
Designing and implementing a minimal and useful quality management system for startups or research providers in the healthcare industries
Sophie MICHEL
Consultant
AMBIOTIS, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
Facility Design and Automation: Smart Manufacturing to Support the Paradigm Shift
- H-Experience Auditorium
Chairman
10h00
AI-Enabled Regulatory Submissions
Sabine LECLERCQ
Founder
Leclercq Biopharma Consulting, Belgium
10h00
Key successes and learning when moving from PD to manufacturing with smart digital technology
Guilherme RAMOS
Data Scientist
DataHow, Switzerland
10h00
Operational AI in CMC: Document Intelligence, Regulatory Insight & Process Risk Reduction
Olivier FAVRE-BULLE
Founder, CEO & Consultant in Drug Development
3Biotech, France
10h00
Title
Anne-Laure LAINE
Director Preclinical Development
Ridgeline Discovery, Switzerland
10h40
Coffee Break at the Exhibition Hall - B2B Meetings
11h10
Workshops
Chairman
12h10
Lunch Break at the Exhibition Hall - B2B Meetings
14h00
Regulatory Perspectives on Bioprocessing
- E-Lounge Auditorium
Chairman
10h00
Regulatory Pathways and Development Cost Optimization for Biosimilars
Fabrice ROMANET
Managing Director & Heading Research & Development Biosimilars
Fresenius Kabi, Switzerland
10h00
The Great Regulatory Convergence: Strategic Navigation of the Evolving Global Biosimilar Landscape and the Implementation of ICH M18
Akash DIXIT
Director & Global Regulatory Affairs Lead
Fresenius Kabi, Switzerland
10h00
Title
Fabrice ROMANET
Managing Director & Heading Research & Development Biosimilars
Fresenius Kabi, Switzerland
15h00
Supply Chain Sustainability: Challenges and Innovative Solutions
- E-Lounge Auditorium
Chairman
10h00
Title
10h00
Title
Alain BECK
Senior Director Biologics CMC and Developability
Pierre Fabre Laboratories, France
16h00
Closing Keynote Lecture
- E-Lounge Auditorium
Chairman
10h00
Title
Guillaume JEANNE
Bioprocess Mechanistic Modeling & Advanced Process Control
Sanofi, France
17h00